Literature DB >> 1639161

Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants.

G S Hui1, S P Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1639161     DOI： 10.1016/0014-4894(92)90131-s

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN： 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  6 in total

1.  Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.

Authors:  Mark Nagata; Teri Wong; David Clements; George Hui
Journal:  Exp Parasitol       Date:  2006-11-21       Impact factor: 2.011

2.  Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts.

Authors:  George Hui; Dan Choe; Caryn Hashimoto
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

3.  Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.

Authors:  G S Hui; C N Hashimoto
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.

Authors:  Kae Pusic; Zoraida Aguilar; Jaclyn McLoughlin; Sophie Kobuch; Hong Xu; Mazie Tsang; Andrew Wang; George Hui
Journal:  FASEB J       Date:  2012-11-29       Impact factor: 5.191

5.  Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.

Authors:  P A Burghaus; B T Wellde; T Hall; R L Richards; A F Egan; E M Riley; W R Ballou; A A Holder
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.

Authors:  J B De Souza; I T Ling; S A Ogun; A A Holder; J H Playfair
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.